Ivabradine for Postoperative JET: Clear for Take-Off?

JACC Clin Electrophysiol. 2021 Aug;7(8):1061-1063. doi: 10.1016/j.jacep.2021.03.015.

Authors

Christopher M Janson¹, Colleen E Clancy²

Affiliations

¹ Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: jansonc@email.chop.edu.
² Department of Physiology and Membrane Biology and Department of Pharmacology, School of Medicine, University of California-Davis, Davis, California, USA.

PMID: 34412869
DOI: 10.1016/j.jacep.2021.03.015

No abstract available

Keywords: congenital heart disease; ivabradine; junctional ectopic tachycardia.

Publication types

Editorial
Comment

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Humans
Ivabradine / therapeutic use
Tachycardia, Ectopic Junctional*

Substances

Anti-Arrhythmia Agents
Ivabradine